NDC Product
Human Prescription DrugMvasi NDC 55513-206
- Generic Name
- Bevacizumab-awwb
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Marketing
- BLA
Active Listing
BEVACIZUMAB
UNII 2S9ZZM9Q9V
Substance Identification & Data
This profile provides standardized clinical and technical data for Bevacizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2S9ZZM9Q9V.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 216974-75-3 and the RxNorm Concept ID (RxCUI) 253337. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
BEVACIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
2S9ZZM9Q9V
The specific atomic composition represented as a molecular structure string.
INN ID
8017
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
KK-78
Identifier assigned by the United States Adopted Names Council.
Substance Type
BEVACIZUMAB
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Bevacizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
BEVACIZUMAB
BEVACIZUMAB BETA
BEVACIZUMAB-AWWB
BEVACIZUMAB-BVZR
BEVACIZUMAB-MALY
Bevacizumab-ADCD
Bevacizumab-NWGD
Bevacizumab-TNJN
Bevacizumab-VIKG
Common Names & Synonyms
AVASTIN
BAT 1706 [WHO-DD]
BAT-1706 (BIOSIMILAR OF BEVACIZUMAB)
BEVACIZUMAB (AVASTIN)
BEVACIZUMAB BIOSIMILAR (ABP-215)
BEVACIZUMAB BIOSIMILAR (AMGEN)
BEVACIZUMAB BIOSIMILAR (CT-P16)
BEVACIZUMAB BIOSIMILAR (FKB-238)
BEVACIZUMAB BIOSIMILAR (GP-2019)
BEVACIZUMAB BIOSIMILAR (PF-06439535)
BEVACIZUMAB BIOSIMILAR (PFIZER)
BEVACIZUMAB BIOSIMILAR - SHANGHAI HENLIUS BIOTECH
BEVACIZUMAB BIOSIMILAR-INNOVENT BIOLOGICS
BEVACIZUMAB [EMA EPAR]
BEVACIZUMAB [JAN]
BEVACIZUMAB [MART.]
BEVACIZUMAB [MI]
BEVACIZUMAB [PURPLE BOOK CDER]
BEVACIZUMAB [USAN]
BEVACIZUMAB [VANDF]
BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED
BEVACIZUMAB-AWWB [PURPLE BOOK CDER]
BI 695502 [WHO-DD]
BS-503
Bevacizumab [WHO-DD]
Bevacizumab adcd [WHO-DD]
Bevacizumab awwb [WHO-DD]
Bevacizumab beta [WHO-DD]
Bevacizumab biosimilar (Amneal Pharmaceuticals)
Bevacizumab biosimilar (mAbxience)
Bevacizumab bvzr [WHO-DD]
Bevacizumab maly [WHO-DD]
Bevacizumab nwgd [WHO-DD]
Bevacizumab tnjn [WHO-DD]
FKB 238 [WHO-DD]
HLX 04 [WHO-DD]
HLX04-O (RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION)
IBI 305 [WHO-DD]
IBI-305
IBI305
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER
LY 01008 [WHO-DD]
LY 01008(BIOSIMILAR OF BEVACIZUMAB)
PF-06439535 [WHO-DD]
QL-1101 (BIOSIMILAR OF BEVACIZUMAB)
USP MAB 002, MONOCLONAL IGG1 [USP-RS]
bevacizumab [INN]
bevacizumab beta [INN]
Brand / Trade Names
ALYMSYS
AVZIVI
BYVASDA
Bevax
JOBEVNE
LYTENAVA
MVASI
Oyavas
VEGZELMA
ZIRABEV
Technical Codes
12-IGG1
ABP-215
AVA-1
BAT-1706
BAT1706
BEVZ-92
BEVZ92
BI-695502
BI695502
BS-503A
CHS-5217
CT-16
CT-P16
CT-P16 (BIOSIMILAR OF BEVACIZUMAB)
CT16
CTP-16
CTP16
FKB-238
FKB238
GP-2019
GP2019
HLX-04
HLX04
HLX04-O
LY 01008
LY-01008
MB-02
MB02
PF-06439535
Q-1101
Q1101
RG-435
RHUMAB-
RO-4876646
NDC Products Containing BEVACIZUMAB
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
